Completed three-year PROTECT randomized controlled trial finds NaturalVue Multifocal 1 Day contact lens slowed myopia progression by 1.06 diopters and eye elongation by 0.58 mm at 36 months.1,2 ANAHEIM, Calif. — Visioneering Technologies, Inc. (VTI), a medical device company that designs and markets specialty contact lenses, will announce completed three-year results from PROTECT, a prospective,…
(RTTNews) - Wednesday, Ernexa Therapeutics (ERNA) reported positive results from three IND-enabling safety studies of ERNA-101, its investigational iMSC therapy for advanced cancers.
Dubai: For years, Lenilyn Arsega did not know she had been living with a congenital heart defect. It was only during a routine check-up while she was eight weeks pregnant that doctors discovered the…
(RTTNews) - Wednesday, Silexion Therapeutics (SLXN) said the first patient has been dosed in its global Phase 2/3 trial evaluating SIL204 in patients with locally advanced pancreatic cancer (LAPC).
You may not know her name, but South African lawyer and bioethicist Kwanele Asante has spent two decades pushing health institutions — from Soweto to the United Nations – to listen to the people their…
